Skip to main content
. 2014 Sep 27;8(6):636–645. doi: 10.1111/irv.12286

Table 2.

Clinical symptoms, complications, treatment and outcomes

All cases (n = 506)
N (%)
Pre-existing conditions (n = 248) Previously healthy (n = 258) P-value
Clinical symptoms
 Cough 340 (67·2) 181 (72·9) 159 (61·6) 0·007
 Fever 260 (51·4) 138 (55·6) 122 (47·3) 0·060
 Coryza 253 (50·0) 125 (50·4) 128 (49·6) 0·895
 Malaise/lethargy 195 (38·5) 106 (42·7) 89 (34·5) 0·057
 Vomiting 163 (32·2) 82 (33·1) 81 (31·4) 0·688
 Dyspnoea 129 (25·5) 73 (29·4) 56 (21·7) 0·046
 Diarrhoea 72 (14·2) 33 (13·3) 39 (15·1) 0·560
 Sore throat 70 (13·8) 43 (17·3) 27 (10·5) 0·025
 Headache 54 (10·7) 36 (14·5) 18 (6·9) 0·006
 Seizure 33 (6·5) 20 (8·1) 13 (5·0) 0·168
Complications (any) 176 (34·8) 92 (37·1) 84 (32·5) 0·284
 Pneumonia 90 (17·8) 45 (18·1) 45 (17·4) 0·836
 Neurological complications (including seizure) 49 (9·7) 27 (10·9) 22 (8·5) 0·370
 Bacterial co-infection 33 (6·5) 22 (8·9) 11 (4·3) 0·036
 Viral co-infection 26 (5·1) 10 (4·0) 16 (6·2) 0·269
 Seizure 17 (3·4) 6 (2·4) 11 (4·3) 0·250
 Pleural effusion 9 (1·8) 5 (2·0) 4 (1·5) 0·692
 ARDS 7 (1·4) 6 (2·4) 1 (0·4) 0·050
 Encephalitis 7 (1·4) 3 (1·2) 4 (1·5) 0·743
POC tests 204 (40·3) 98 (39·5) 106 (48·1) 0·393
Treatment
 Oseltamivir 238 (47·0) 165 (66·5) 73 (28·3) 0·000
 Zanamivir 3 (0·6) 2 (0·8) 1 (0·4)
 Antibiotics 273 (54·0) 154 (62·1) 119 (46·1) 0·762
Outcomes
 Death 5 (0·9) 1 (0·4) 4 (1·5) 0·192
 LOS in hospital: mean(SD) days 5·9 (10·8) 6·9 (10·6) 4·9 (10·9) 0·026
 PICU admission 50 (9·9) 32 (12·9) 18 (6·9) 0·005
 LOS in PICU: mean (SD) days 5·3 (6·4) 7·0 (7·2) 2·3 (2·5) 0·005
 Ventilated 30 (5·9) 20 (8·1) 10 (3·9) 0·058
 Duration of ventilation: mean (SD) days 6·8 (11·7) 7·5 (12·5) 5·5 (10·5) 0·888

ARDS, Acute respiratory distress syndrome; LOS, length of hospital stay; SD, standard deviation; POC, Point of care tests (rapid antigen test).

Bold values indicates significant difference between groups.